Colony stimulating factors in patients with fever and neutropenia.
Colony stimulating factors (CSFs), are essential for the regulation of the hematopoietic system and were developed by the pharmaceutical biotechnology industry in the early 1990s for the prevention of serious neutropenic complication after myelosuppressive chemotherapy. Both G-CSF and GM-CSF consistently lead to an increase in circulating white blood cells and a reduction in the incidence of fever and neutropenia after myelosuppressive chemotherapy in patients with solid tumors, hematologic malignancies, and those undergoing stem-cell transplantation. Their role in improving response rates to chemotherapy and overall survival is less clear.
Rubenstein
E B
EB
University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005334:Fever / Q000150:complications*; D006801:Humans; D007239:Infections / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D003115:Colony-Stimulating Factors